Analysis of phenotype and gene mutation in three pedigrees with inherited antithrombin deficiency. Issue 11 (21st October 2022) - Li, Min
Abstract: Background: Inherited AT deficiency is an autosomal‐dominant thrombophilic disorder usually caused by various SERPINC1 defects associated with a high risk of recurrent venous thromboembolism. In this article, the phenotype, gene mutation, and molecular pathogenic mechanisms were determined in three pedigrees with inherited AT deficiency. Methods: Coagulation indices were examined on STAGO STA‐R‐MAX analyzer. The AT:Ag was analyzed by ELISA. All exons and flanking sequences of SERPINC1 were amplified by PCR. AT wild type and three mutant expression plasmids were constructed and then transfected into HEK293FT cells. The expression level of AT protein was analyzed by ELISA and Western blot. Results: The AT:A and AT:Ag of probands 1 and 3 were decreased to 49% and 52 mg/dL, 38% and 44 mg/dL, respectively. The AT:A of proband 2 was decreased to 32%. The SERPINC1 gene analysis indicated that there was a p.Ile421Thr in proband 1, a p.Leu417Gln in proband 2, and a p.Met252Thr in proband 3, respectively. The AT mRNA expression level of the three mutants was not significantly different from AT‐WT by qRT‐PCR. The results of ELISA and Western blot tests showed that the AT‐M252T and AT‐I421T mutants had a higher AT expression than the AT wild type (AT‐WT), and the AT protein expression of AT‐L417Q mutants had no significant difference compared with AT‐WT in the cell lysate. The AT expression levels of AT‐M252T and AT‐I421T mutants were lower than that of AT‐WT, and there was no significant difference between AT‐L417Q mutant and AT‐WT in the supernatant. Conclusion: The p.I421T and p.M252T mutations affected the secretion of AT protein leading to type I AT deficiency of probands 1 and 3. The p.Leu417Gln mutation was responsible for the impaired or ineffective activity AT protein in proband 2 and caused type II AT deficiency. Abstract : In this article, the results showed that three mutations did not affect the expression of AT gene transcription level, but the p.M252T and p.I421T mutations reduced the secretion of AT protein and leading to type I AT deficiency. The p. L417Q mutation leading to type II AT deficiency by synthesized dysfunctional AT molecules to reducing AT:A.